How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Sell
45
XPH Quote, Financials, Valuation and Earnings
Last price:
$44.03
Seasonality move
:
0.25%
Day range:
$43.08 - $43.47
52-week range:
$38.88 - $48.76
Dividend yield:
1.56%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
86.6K
Avg. volume:
63.1K
1-year change:
5.83%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingSPDR S&P Pharmaceuticals ETF has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, SPDR S&P Pharmaceuticals ETF has an estimated downside of -- from its current price of $43.41.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $43.41.
Fair Value
-
According to the consensus of 0 analysts, SPDR S&P Pharmaceuticals ETF has -- downside to fair value with a price target of -- per share.
XPH vs. S&P 500
-
Over the past 5 trading days, SPDR S&P Pharmaceuticals ETF has underperformed the S&P 500 by -4.9% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
SPDR S&P Pharmaceuticals ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SPDR S&P Pharmaceuticals ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter SPDR S&P Pharmaceuticals ETF reported revenues of --.
Earnings Growth
-
SPDR S&P Pharmaceuticals ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter SPDR S&P Pharmaceuticals ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-27 | 2023-12-27 | 2023-12-27 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-27 | 2021-12-27 | 2022-12-27 | 2023-12-27 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-27 | 2023-12-27 | 2023-12-27 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
XPH
Sector
Market Cap
--
--
Price % of 52-Week High
89.03%
--
Dividend Yield
1.56%
--
Shareholder Yield
--
--
1-Year Price Total Return
5.83%
--
Beta (5-Year)
0.759
--
Dividend yield:
1.56%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$43.90
200-day SMA
Buy
Level
$42.92
Bollinger Bands (100)
Sell
Level
43.27 - 46.31
Chaikin Money Flow
Buy
Level
15.5M
20-day SMA
Sell
Level
$45.07
Relative Strength Index (RSI14)
Sell
Level
34.73
ADX Line
Sell
Level
11.63
Williams %R
Buy
Level
-86.4615
50-day SMA
Sell
Level
$45.91
MACD (12, 26)
Sell
Level
-0.68
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Neutral
Level
16.1M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, XPH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The XPH average analyst price target in the past 3 months is --.
-
Where Will SPDR S&P Pharmaceuticals ETF Stock Be In 1 Year?
According to analysts, the consensus estimate is that SPDR S&P Pharmaceuticals ETF share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About SPDR S&P Pharmaceuticals ETF?
Analysts are divided on their view about SPDR S&P Pharmaceuticals ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SPDR S&P Pharmaceuticals ETF is a Sell and believe this share price will rise from its current level to --.
-
What Is SPDR S&P Pharmaceuticals ETF's Price Target?
The price target for SPDR S&P Pharmaceuticals ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is XPH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SPDR S&P Pharmaceuticals ETF is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of XPH?
You can purchase shares of SPDR S&P Pharmaceuticals ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SPDR S&P Pharmaceuticals ETF shares.
-
What Is The SPDR S&P Pharmaceuticals ETF Share Price Today?
SPDR S&P Pharmaceuticals ETF was last trading at $44.03 per share. This represents the most recent stock quote for SPDR S&P Pharmaceuticals ETF. Yesterday, SPDR S&P Pharmaceuticals ETF closed at $43.41 per share.
-
How To Buy SPDR S&P Pharmaceuticals ETF Stock Online?
In order to purchase SPDR S&P Pharmaceuticals ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
60
QMCO alert for Dec 26
Quantum [QMCO] is up 49.62% over the past day.
Buy
53
ARQQ alert for Dec 26
Arqit Quantum [ARQQ] is up 49.85% over the past day.
Buy
65
TSLL alert for Dec 26
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 3.73% over the past day.
